Proton pump inhibitors versus H2-antagonists: A meta-analysis of their efficacy in treating bleeding peptic ulcer

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 7, 2001, Pages 917-926

  Gisbert, J P ^a,d   Gonzalez L ^a   Calvet, X ^b   Roque M ^c   Gabriel, R ^a   Pajares, J M ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b Servei de Medicina   (Spain)

^c Center d'Estudis   (Spain)

^d NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ARTICLE; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DUODENUM BLEEDING; DUODENUM ULCER; ENDOSCOPIC SCLEROTHERAPY; ENDOSCOPIC THERAPY; HIGH RISK PATIENT; HUMAN; MEDICAL INFORMATION; META ANALYSIS; MORTALITY; PATIENT CODING; PRIORITY JOURNAL; PUBLICATION; RECURRENT DISEASE; STOMACH HEMORRHAGE; STOMACH SURGERY; STOMACH ULCER;

ANTI-ULCER AGENTS; ENDOSCOPY; ENZYME INHIBITORS; HISTAMINE H2 ANTAGONISTS; HUMANS; PEPTIC ULCER; PEPTIC ULCER HEMORRHAGE; PROTON PUMPS; RECURRENCE; TREATMENT OUTCOME;

EID: 0034954707     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.01012.x     Document Type: Article

References (51)

1. Bleeding peptic ulcer
2. Natural history of duodenal ulcer disease: Are we at a turning point?
3. Epidemiology of upper gastrointestinal bleeding
4. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor to prolonged gastroduodenal mucosal hemorrhage
5. Pharmacological manipulation of gastric juice: Thrombelastographic assessment and implications for treatment of gastrointestinal haemorrhage
6. Clot lysis by gastric juice: An in vitro study
7. The effect of pH on platelet and coagulation factor activities
8. Nonvariceal upper gastrointestinal bleeding: An update
9. 2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials
10. 2-receptor antagonists in gastroduodenal ulcer haemorrhage
11. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetldine and ranitidine
12. Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer
13. Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer
14. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse
15. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: A preliminary report of a randomized comparative study
16. Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer
17. Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer
18. A comparison of omeprazole and placebo for bleeding peptic ulcer
19. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study
20. Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study
21. Omeprazole versus placebo for acute upper gastrointestinal bleeding: Randomised double blind controlled trial
22. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
23. Stigmata of recent haemorrhage in diagnosis and prognosis of upper gastrointestinal bleeding
24. Cochrane Reviewers's Handbook 4.0
25. Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: A prospective randomised controlled study
26. Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: An open randomized controlled trial
27. The treatment of upper digestive hemorrhage of peptic origin: Intravenous ranitidine versus intravenous omeprazole
28. Does the antisecretory agent used affect the evolution of upper digestive hemorrhage?
29. Omeprazole and cimetidine in the treatment of upper digestive hemorrhage
30. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy
31. Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: A prospective and randomized study
32. Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study
33. Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: A prospective randomized study
34. The efficacy of proton-pump inhibitors in acute ulcer bleeding: A qualitative review
35. Bolus or intravenous infusion of ranitidine: Effects on gastric pH and acid secretion. A comparison of relative efficacy and cost
36. Randomized comparison of gastric pH control with intermittent and continuous intravenous infusion of famotidine in ICU patients
37. Control of gastric pH with cimetidine: Boluses versus primed infusions
38. Sustained fasting achlorhydria: A comparison of medical regimens
39. Omeprazole pharmacokinetics and metabolism in man
40. Drugs for pH control in upper gastrointestinal bleeding
41. Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage
42. Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage: A meta-analysis
43. Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer
44. Factors related to the failure of endoscopic therapy for bleeding gastric ulcer
45. Tolerance during dosing with H2-receptor antagonists. An overview
46. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
47. Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine
48. Acute haemorrhagic gastritis controlled by omeprazole
49. Long term management of hemorrhagic esophagitis with cimetidine and omeprazole
50. Life-threatening gastrointestinal hemorrhage with omeprazole
51. Use of intravenous omeprazole in emergency cases of gastroduodenal hemorrhage